2Harding SM.The human pharmacology of fluticasone propionate.Respir Med,1990,84(suppl A):25—29.
3Falcoz C,Mackie AE,McDowall J,et a1.Oral bioavailability of fluticasone propionate in healthy subjects.Br J Clin Pharmacol,1996,41:459—460.
4Hoekx JC,Hedlin G,Pedesen W,et a1.Fluticasone propionate compared budesonide:A double.blind trial in asthmatic children using powder devices at a dosage of 400 microg×day(-1).Eur Respir J,1996,9(11):2263—2272.
5Allen DB,Bronskg EA,Lafone CF,et al.Fluticasone Propionate Asthma Study Group.Growth in asthmatic children treated with fluticasone propionate.J Pediatr,1998,132(3 Pt 1):472—477.
6Price JF.Russenll G,Hindmarsh PC,et a1.Growth during one year of treatment with fluticasone propionate or sodium cromoglycate in children with asthma.Pediatr Pulmonol.1997,24(3):178—186.
7Pauwels RA,Yernault JC,Demedts MG,et al.Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma.Belgian Multicenter Study Group.Am J Respir Crit Care med.1998,157(3 Pt 1):827-832.
8Ayres JG,Bateman ED,Lundback B,et al.High dose fluticasone propionate,1 mg daily,versus fluticasone propionate,2 mg daily,or budesonide,1.6 mg daily,in patients with chronic severe asthma.International Study Group.Eur Respir J,1995,8(4):579-586.
9Galant SP,van Bavel J,Finn A,et al.Diskus and diskhaler:efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.Ann Allergy Asthma Immunol,1999,82(3):273-280.
10Li JT,Ford LB,Chervinsky P,et al.Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma.J Allergy Clin Immunol,1999,103(6):1062-1068.
